0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Blood Disorders Caused by Drug Sensitivity

M. M. WINTROBE, M.D.; G. E. CARTWRIGHT, M.D.
AMA Arch Intern Med. 1956;98(5):559-566. doi:10.1001/archinte.1956.00250290019004.
Text Size: A A A
Published online

The Problem  In 1922, Werner Schultz1 described a syndrome which ultimately came to be known as agranulocytosis. At first but a few cases were recognized, but between 1929 and 1934 a large number were reported. About this time (1931) Kracke2 noted that the sudden appearance and growing number of cases of agranulocytosis corresponded with the introduction of certain coal-tar derivatives as therapeutic agents. The disorder was especially common in the countries in which such drugs were in great use, and those affected were chiefly women of good economic status as well as nurses and other medical workers to whom these drugs were easily accessible. Shortly afterward several reports appeared* which incriminated aminopyrine (Pyramidon) as the offending drug. After 1934 the number of cases of agranulocytosis began to decrease. This coincided with the reduced sales of aminopyrine following reports of its injurious effects.5Later, however, as new drugs

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();